Target intelligence / Profile preview

Kv1.3 potassium voltage-gated channel subfamily A member 3 (Kv1.3)

Target
Kv1.3
Molecular classification
Ion channel, Voltage-gated potassium channel, Shaker-type potassium channel, Tetrameric channel family
01

Overview

Kv1.3 potassium voltage-gated channel subfamily A member 3 is a tetrameric ion channel found primarily on immune cells, such as T lymphocytes and microglia. Structurally, each subunit contains six transmembrane segments with distinct voltage-sensing and ion-conducting domains, featuring a highly conserved selectivity filter that discriminates potassium from sodium ions. Kv1.3 channels regulate the membrane potential and calcium-dependent signaling pathways crucial for immune cell activation and proliferation. Functionally, they are integral to immune responses, and their upregulation is notable in several autoimmune and neuroinflammatory conditions. Kv1.3 blockade is being explored as an immunosuppressive therapeutic strategy in the treatment of these diseases. Despite promise, systemic inhibition may pose immunosuppressive risks and off-target effects due to the channel's broader expression profile. The molecular characterization and strong evidence linking Kv1.3 to disease pathology establish it as a significant drug target.

Other names
Kv1.3KCNA3Shaker-related potassium channelvoltage-gated potassium channel subfamily A member 3
02

Mechanism of action

Channel blockade (inhibition of potassium efflux, leading to altered membrane potential and suppressed T cell activation); Stabilization of channel selectivity filter (peptides/nanobodies can lock the channel in a non-conducting or open state); Immunosuppression by impairing calcium signaling in effector T cells

03

Biological functions

Regulation of membrane potentialCellular activationControl of cell proliferationCell death (apoptosis)Calcium signaling regulationCytokine secretionCellular homeostasis of immune cellsMetabolic regulation of proliferation through non-conducting channel activities
04

Disease associations

Autoimmune diseasesCancerNeuroinflammatory diseasesObesity and metabolic disordersOther inflammatory diseases
05

Safety considerations

Potential immunosuppressionOff-target effectsChannel redundancy
06

Interacting drugs

Dalazatide (ShK-186)

4 more in the full profile.

07

Biomarkers

Kv1.3 expression levels in T cells and microgliaElevated Kv1.3 in disease-specific immune cell subsets, e.g., TEM cells in autoimmune disease

Beyond the preview

Go deeper on Kv1.3 potassium voltage-gated channel subfamily A member 3 (Kv1.3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kv1.3 potassium voltage-gated channel subfamily A member 3 (Kv1.3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call